1651 related articles for article (PubMed ID: 24251707)
1. Characteristics and diagnosis of NAFLD/NASH.
Hashimoto E; Taniai M; Tokushige K
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic criteria for non-alcoholic steatohepatitis].
Hashimoto E
Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
[TBL] [Abstract][Full Text] [Related]
3. Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.
Tokushige K; Hashimoto E; Kodama K
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():88-92. PubMed ID: 24251711
[TBL] [Abstract][Full Text] [Related]
4. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
5. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
8. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
Serfaty L; Lemoine M
Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease.
Vizzutti F; Arena U; Nobili V; Tarquini R; Trappoliere M; Laffi G; Marra F; Pinzani M
Ann Hepatol; 2009; 8(2):89-94. PubMed ID: 19502649
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease.
Smith BW; Adams LA
Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
[TBL] [Abstract][Full Text] [Related]
11. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
12. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
[TBL] [Abstract][Full Text] [Related]
13. Pathology and biopsy assessment of non-alcoholic fatty liver disease.
Straub BK; Schirmacher P
Dig Dis; 2010; 28(1):197-202. PubMed ID: 20460911
[TBL] [Abstract][Full Text] [Related]
14. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
[TBL] [Abstract][Full Text] [Related]
15. [Non-alcoholic fatty liver].
Tagle Arrospide M
Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
[TBL] [Abstract][Full Text] [Related]
16. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
Balmer ML; Dufour JF
Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of the measurement of serum cytokeratin-18 in patients with non-alcoholic steatohepatitis].
Watanabe T; Takemura M; Saito K; Ito H; Hattori T; Sekine A; Yamada K; Kato T; Tomita E; Matsuoka T; Seishima M
Rinsho Byori; 2013 Jan; 61(1):19-24. PubMed ID: 23672077
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges.
Hashimoto E; Tokushige K; Ludwig J
Hepatol Res; 2015 Jan; 45(1):20-8. PubMed ID: 24661406
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
20. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
Yilmaz Y
Aliment Pharmacol Ther; 2012 Nov; 36(9):815-23. PubMed ID: 22966992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
